Gapping up
In reaction to strong earnings/guidance: LITB +10.2%, SAP +0.7% (guidance)
M&A news: HTS +8.4% (to be acquired by Annaly Capital Management (NLY) for $15.85/share in cash)
Select EU financial related names showing strength: BCS +3.3%, ING +3.3%, CS +2.4%, RBS +2.2%, LYG +1.6%,DB +1.6%, HSBC +1.4%
Select metals/mining stocks trading higher: AU +6.1%, IAG +3.2%, PAAS +3.1%, MT +2.8%, RIO +2.6%, SLV+2.5%, BHP +2.4%, GDX +2.1%, SLW +1.8%, HMY +1.8%, CLF +1%
Other news: SUNE +11.6% (continued volatility in the pre-mkt action), VKTX +11.6% (presents 'positive' phase 1b clinical data on VK2809 in hypercholesterolemic subjects), CANF +8.4% (announces new pre-clinical data for cf602 demonstrating 'statistically significant full recovery' from erectile dysfunction after a single dose), TRXC +5.7% (still checking), CHK +5.1% (announces amendment to revolving credit facility; borrowing base reaffirmed at $4.0 billion), PRAN+3.5% (regains compliance with Nasdaq continued listing requirements continues to work towards FDA submission), AUY+2.8% (announces Q1 production; updates outlook including Riacho Dos Machados), VRX +1.6% (Board requests CEO J. Michael Pearson cooperate in connection with a subpoena for deposition from the Senate Committee on Aging)
In reaction to strong earnings/guidance: LITB +10.2%, SAP +0.7% (guidance)
M&A news: HTS +8.4% (to be acquired by Annaly Capital Management (NLY) for $15.85/share in cash)
Select EU financial related names showing strength: BCS +3.3%, ING +3.3%, CS +2.4%, RBS +2.2%, LYG +1.6%,DB +1.6%, HSBC +1.4%
Select metals/mining stocks trading higher: AU +6.1%, IAG +3.2%, PAAS +3.1%, MT +2.8%, RIO +2.6%, SLV+2.5%, BHP +2.4%, GDX +2.1%, SLW +1.8%, HMY +1.8%, CLF +1%
Other news: SUNE +11.6% (continued volatility in the pre-mkt action), VKTX +11.6% (presents 'positive' phase 1b clinical data on VK2809 in hypercholesterolemic subjects), CANF +8.4% (announces new pre-clinical data for cf602 demonstrating 'statistically significant full recovery' from erectile dysfunction after a single dose), TRXC +5.7% (still checking), CHK +5.1% (announces amendment to revolving credit facility; borrowing base reaffirmed at $4.0 billion), PRAN+3.5% (regains compliance with Nasdaq continued listing requirements continues to work towards FDA submission), AUY+2.8% (announces Q1 production; updates outlook including Riacho Dos Machados), VRX +1.6% (Board requests CEO J. Michael Pearson cooperate in connection with a subpoena for deposition from the Senate Committee on Aging)
Analyst comments: HCM +1.5% (initiated with a Buy at BofA/Merrill)